Product Code: VMR112110059
Global Poultry Vaccines Market size is anticipated to grow from USD 2.56 Billion in 2024 to USD 5.06 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.85% during the forecast period of 2026 to 2033.
The poultry vaccines market is experiencing significant growth as the demand for healthy and disease-free poultry production continues to rise globally. Vaccination is a crucial component of poultry health management, helping to prevent outbreaks of diseases such as avian influenza, Newcastle disease, and infectious bronchitis. With the increasing awareness of food safety and the need for sustainable poultry farming practices, the demand for effective vaccines is expected to grow. As the market evolves, the emphasis on research and development, product efficacy, and regulatory compliance will be crucial in attracting poultry producers seeking reliable vaccination solutions.
Moreover, advancements in vaccine technology are enhancing the capabilities of poultry vaccines. Innovations such as recombinant vaccines, live attenuated vaccines, and inactivated vaccines are enabling manufacturers to develop products that offer improved protection and reduced side effects. The integration of delivery systems, such as water-based and aerosol vaccines, is also gaining traction, allowing for more efficient administration and better uptake among poultry populations. As the poultry vaccines market continues to grow, the focus on innovation and consumer engagement will play a vital role in shaping its future trajectory.
In addition, the growing trend of biosecurity measures and animal welfare is influencing the poultry vaccines market. As producers seek to minimize disease risks and enhance the health of their flocks, there is a rising demand for vaccines that align with these goals. This shift is prompting manufacturers to invest in marketing and distribution strategies that highlight the benefits of vaccination in promoting poultry health and productivity. The future of the poultry vaccines market is thus characterized by a commitment to quality, innovation, and the continuous improvement of vaccination solutions to meet the evolving needs of the poultry industry.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
SEGMENTATION COVERED IN THE REPORT
By Product Type
- Modified or Attenuated (Live)
- Inactivated (Killed)
- Recombinants
By Dosage Form
- Liquid Vaccine
- Freeze Dried Vaccine
- Duct
By Disease Type
- Newcastle Disease
- Marek's Disease
- Infectious Bronchitis
- Infectious Bursal Disease
- Others
By Application
By End User
- Hospitals
- Poultry Vaccination Centres
- Poultry Firms
- COMPANIES PROFILED
- Zoetis
- Boehringer Ingelheim
- Merck Animal Health
- Elanco Animal Health
- Dechra Pharmaceuticals
- Phibro Animal Health
- Hester Biosciences
- Novartis Animal Health
- Ceva Sante Animale
- Venky's India Ltd.
- The above list can be customized.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . POULTRY VACCINES INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Disease Type
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
5. MARKETING CHANNEL
- 5.1. Direct Marketing
- 5.2. Indirect Marketing
- 5.3. Marketing Channel Development Trend
6 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY APPLICATION
- 6.1 Overview by Application
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Application
- 6.4 Broiler Historic and Forecast Sales by Regions
- 6.5 Layer Historic and Forecast Sales by Regions
- 6.6 Breeder Historic and Forecast Sales by Regions
7 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY PRODUCT
- 7.1 Overview by Product
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Product
- 7.4 Attenuated Live Vaccines Historic and Forecast Sales by Regions
- 7.5 Inactivated Vaccines Historic and Forecast Sales by Regions
- 7.6 Subunit Vaccines Historic and Forecast Sales by Regions
- 7.7 DNA Vaccines Historic and Forecast Sales by Regions
- 7.8 Recombinant Vaccines Historic and Forecast Sales by Regions
8 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY DISEASE TYPE
- 8.1 Overview by Disease Type
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Disease Type
- 8.4 Infectious Bronchitis Historic and Forecast Sales by Regions
- 8.5 Infectious Bursal Diseases Historic and Forecast Sales by Regions
- 8.6 Infectious Laryngotracheitis Historic and Forecast Sales by Regions
- 8.7 Egg Drop Syndrome Historic and Forecast Sales by Regions
- 8.8 Adenovirus Historic and Forecast Sales by Regions
- 8.9 Duck Viral Enteritis Historic and Forecast Sales by Regions
- 8.10 Inclusion Body Hepatitis Historic and Forecast Sales by Regions
- 8.11 Coccidiosis Historic and Forecast Sales by Regions
- 8.12 Avian Influenza Historic and Forecast Sales by Regions
- 8.13 Marek's Disease Historic and Forecast Sales by Regions
- 8.14 Newcastle Disease Historic and Forecast Sales by Regions
- 8.15 Salmonella Historic and Forecast Sales by Regions
- 8.16 Avian Encephalomyelitis Historic and Forecast Sales by Regions
- 8.17 Fowl Cholera Historic and Forecast Sales by Regions
9 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY GEOGRAPHY
- 9.1. Regional Outlook Sales Analysis
- 9.2. Introduction Sales Analysis
- 9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
- 9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
- 9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
- 9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
- 9.7. Middle East Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East Africa by Segment Sales Analysis
- 9.7.3. Middle East Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE POULTRY VACCINES COMPANIES
- 10.1. Poultry Vaccines Market Competition
- 10.2. Partnership/Collaboration/Agreement
- 10.3. Merger And Acquisitions
- 10.4. New Product Launch
- 10.5. Other Developments
11 . COMPANY PROFILES OF POULTRY VACCINES INDUSTRY
- 11.1. Top 10 Company Share Analysis
- 11.2. Market Concentration Rate
- 11.3. Boehringer Ingelheim International GmbH
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
- 11.4. Ceva
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
- 11.5. Zoetis
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
- 11.6. Elanco
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
- 11.7. Intervet Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
- 11.8. Merck Co. Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
- 11.9. Hester Biosciences Limited
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
- 11.10. Vaxxinova International BV
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
- 11.11. Venkys India
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
- 11.12. Calier
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
- 11.13. KM Biologics
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
- 11.14. Phibro Animal Health Corporation
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies